TrialNature medicine2023

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Zachary D Crees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.